Our website use cookies to improve and personalize your experience and to display advertisements (if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies.

Ok, I Agree
May
13
2021
By The African Mirror
Should my teen get the COVID-19 vaccine?

Should my teen get the COVID-19 vaccine?

COVID-19
MICHAEL ERMAN THE U.S. Food and Drug Administration has authorized Pfizer and BioNTech's COVID-19 vaccine for use in children as young as 12, widening the country's inoculation program as vaccination rates have slowed significantly. The following information should help parents deciding whether to inoculate their adolescent children. IS THE VACCINE SAFE FOR 12-15 YEAR OLDS? The FDA found the vaccine to be safe and effective in Pfizer's clinical trial. That trial included 2,260 participants in that age group, half of whom received the same vaccine dose given to adults. The other half got a placebo as a comparison group. The…
Read More
May
09
2021
By The African Mirror
WHO approves Sinopharm

WHO approves Sinopharm

COVID-19
STEPHANIE NEBEHAY THE World Health Organization (WHO) has approved for emergency use a COVID-19 vaccine from China's state-owned drugmaker Sinopharm, bolstering Beijing's push for a bigger role in inoculating the world. The vaccine, one of two main Chinese coronavirus vaccines that have been given to hundreds of millions of people in China and elsewhere, is the first developed by a non-Western country to win WHO backing. It is also the first time the WHO has given emergency use approval to a Chinese vaccine for any infectious disease. Earlier this week, separate WHO experts had expressed concern about the quality of…
Read More
May
06
2021
By The African Mirror
Egypt 4.9 million doses in May

Egypt 4.9 million doses in May

COVID-19
EGYPT will receive another 4.9 million doses of different types of coronavirus vaccines in May. The earliest of these will be a shipment of 1.7 million doses of the AstraZeneca COVID-19 vaccine which is due to arrive next week as part of the global COVAX agreement, the Egyptian cabinet said in a statement. COVAX was established by the Geneva-based GAVI vaccine alliance and the World Health Organisation (WHO) for the equitable distribution of vaccines. Egypt will receive an additional shipment of 1.7 million AstraZeneca vaccines by the end of May, 1 million doses of the Chinese Sinopharm vaccine to arrive…
Read More
May
01
2021
By The African Mirror
AstraZeneca Q1 COVID-19 vaccine revenue $275 mln

AstraZeneca Q1 COVID-19 vaccine revenue $275 mln

BUSINESS
ASTRAZENECA has revealed that its COVID-19 vaccine contributed $275 million in sales and shaved off three cents per share from its first-quarter earnings, as the drugmaker reported better-than-expected results and forecast sales growth. This is the first time the drugmaker has given financial details from the distribution and sales of its vaccine. It has said it will not make a profit from the shot during the pandemic. Vaccine revenue included delivery of about 68 million doses worldwide, it said. Sales in Europe were $224 million, emerging market sales were $43 million, and $8 million in the rest of the world,…
Read More
Apr
30
2021
By The African Mirror
Moderna targets up to 3-billion shots in 2022

Moderna targets up to 3-billion shots in 2022

COVID-19
CARL O’DONNELL and JULIE STEENHUYSEN  MODERNA Inc said on Thursday it is boosting manufacturing capacity for its COVID-19 vaccine and expects to make up to 3 billion doses in 2022, more than twice its previous forecast. It also said it is increasing its expectations for 2021 vaccine production to between 800 million and 1 billion shots, raising the bottom of its range from 700 million. The final number of inoculations will depend on how many are lower-dose formulations for boosters and immunizations for children. Moderna shots currently deploy 100 micrograms of vaccine substance but some future shots may use only…
Read More
Apr
28
2021
By The African Mirror
Kenyan tour guides take COVID-19 vaccine in hopes of tourism revival

Kenyan tour guides take COVID-19 vaccine in hopes of tourism revival

COVID-19
AROUND 250 tour guides from Kenya's famed national parks lined up in downtown Nairobi yesterday to receive the COVID-19 vaccination, as part of a government effort to revive the tourism sector that has been battered by the pandemic. The vaccination drive comes ahead of the annual wildebeest migration across the Maasai Mara National Reserve. The migration typically draws several hundred thousand international visitors but last year drew a far smaller number of local tourists. Kenya's tourism sector lost close to $1 billion in revenue between January and October of last year, when the number of foreign visitors plunged by two…
Read More
Apr
27
2021
By The African Mirror
South African study using J&J vaccine will resume

South African study using J&J vaccine will resume

COVID-19
SOUTH African researchers will tomorrow resume a study further evaluating the efficacy of Johnson & Johnson's COVID-19 vaccine in the field, after it was temporarily suspended along with use of the shot in the United States. U.S. regulators recommended pausing the use of the single-shot earlier this month due to extremely rare cases of blood clots but on Friday said the United States could restart vaccinations. Europe's drug regulator has backed its overall benefits against any risk. The Sisonke study is being carried out by the National Department of Health, South African Medical Research Council and Johnson & Johnson among…
Read More
Apr
21
2021
By The African Mirror
J&J reports $100 million in vaccine sales as results top forecasts

J&J reports $100 million in vaccine sales as results top forecasts

BUSINESS
JOHNSON & Johnson beat expectations for quarterly earnings and raised its dividend payouts to shareholders yesterday, while reporting $100 million in sales of its COVID-19 vaccine, whose use was paused by U.S. regulators last week. The company, which has previously said the vaccine will be available on a not-for-profit basis until the end of the pandemic, also tightened its forecast for adjusted profit this year, suggesting it was largely performing as previously expected. Use of the company's vaccine was temporarily halted by U.S. regulators as they investigate reports of blood clots in six women, prompting a similar pause in South…
Read More
Apr
21
2021
By The African Mirror
Some countries limit AstraZeneca vaccine use, EU findings on J&J shot expected

Some countries limit AstraZeneca vaccine use, EU findings on J&J shot expected

COVID-19
SOME countries are restricting use of the AstraZeneca COVID-19 vaccine to certain age groups, or suspending use, after European and British regulators confirmed possible links to rare blood clots. Johnson & Johnson's vaccine has also been hit by concerns over blood clots. European regulators will issue findings later of their review into clotting issues in adults who had received the shot in the United States. U.S. health agencies recommended pausing the single shot's use temporarily on April 13 after reports of six cases in women under 50. A health advisory panel will meet on April 23 to discuss whether the…
Read More
Apr
20
2021
By The African Mirror
FACTBOX: How countries use vaccines

FACTBOX: How countries use vaccines

COVID-19
SOME countries are restricting the use of the AstraZeneca COVID-19 vaccine to certain age groups, or suspending use, after European and British regulators confirmed possible links to rare blood clots. Johnson & Johnson's single-shot vaccine has also been hit by concerns over blood clots. European regulators are reviewing such cases and are expected to issue findings on April 20. U.S. federal health agencies recommended pausing its use temporarily on April 13 and a U.S. health advisory panel will meet on April 23 to discuss whether the pause should continue. J&J has stated that no clear causal relationship has been established…
Read More
Facebook
Twitter
Linkedin
Instagram